Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Meister

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Aktuelle Urologie|July 30, 2020
Andreas Wiedemann, Thomas Meister
Biorxiv : the Preprint Server for Biology|August 26, 2024
A fast-acting inhibitor of blood-stage <i>P. falciparum</i> with mechanism distinct from artemisinin and chloroquineStephanie Kabeche, Thomas Meister, Ellen Yeh
Energy, Sustainability and Society|March 28, 2020
How municipalities support energy cooperatives: survey results from Germany and SwitzerlandThomas Meister, Benjamin Schmid, Irmi Seidl, et al.
Antimicrobial Agents and Chemotherapy|July 22, 2024
A picomolar inhibitor of the <i>Plasmodium falciparum</i> IPP pathwayStephanie Kabeche, Thomas Braukmann, Jon Doenier, et al.
Pharmaceutics|April 26, 2025
The Clinical Utility of Precision-Guided Dosing for Adalimumab Therapy Optimization in Inflammatory Bowel Disease: A Clinical Experience ProgramStephen B Hanauer, Esther A Torres, Patricia Aragon-Han, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Aktuelle Urologie|July 30, 2020
Andreas Wiedemann, Thomas Meister
Biorxiv : the Preprint Server for Biology|August 26, 2024
A fast-acting inhibitor of blood-stage <i>P. falciparum</i> with mechanism distinct from artemisinin and chloroquineStephanie Kabeche, Thomas Meister, Ellen Yeh
Energy, Sustainability and Society|March 28, 2020
How municipalities support energy cooperatives: survey results from Germany and SwitzerlandThomas Meister, Benjamin Schmid, Irmi Seidl, et al.
Antimicrobial Agents and Chemotherapy|July 22, 2024
A picomolar inhibitor of the <i>Plasmodium falciparum</i> IPP pathwayStephanie Kabeche, Thomas Braukmann, Jon Doenier, et al.
Pharmaceutics|April 26, 2025
The Clinical Utility of Precision-Guided Dosing for Adalimumab Therapy Optimization in Inflammatory Bowel Disease: A Clinical Experience ProgramStephen B Hanauer, Esther A Torres, Patricia Aragon-Han, et al.
Pageof 1